Your trusted destination for CME, CPD & Medical Education across the Middle East.
This two-day SSBMT conference brings together regional and international experts to share the latest developments in lymphoma, multiple myeloma, and hematopathology. Through expert-led lectures, scientific discussions, and clinical case sessions, the program explores advances in diagnosis, treatment, and emerging approaches to managing complex hematological disorders.
The 7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview is a premier educational conference organized by the Saudi Society of Blood & Marrow Transplantation (SSBMT). Taking place in Dhahran, this event brings together leading local and international experts to discuss the latest advancements in the diagnosis and treatment of lymphoproliferative disorders, multiple myeloma, and various hematological conditions. The program features state-of-the-art lectures, evidence-based hematology sessions, and satellite symposia covering technological developments in flow cytometry, molecular markers, and stem cell transplantation. It is an essential gathering for hematologists, oncologists, pathologists, and allied healthcare professionals seeking to enhance their clinical practice and foster regional collaboration.
Exploring frontline treatments for transplant-eligible and ineligible patients.
Current landscape, future directions, and the use of CAR-T vs. Bispecific therapy.
Latest updates and a summary of new response criteria in Multiple Myeloma.
Evaluating the need for autologous transplants and rewriting second-line therapies.
How immunotherapy is changing the treatment landscape for early-stage Hodgkin Lymphoma.
Best management strategies for relapsed/refractory cases.
Utilization in the diagnosis of hematological malignancies.
Diagnostic classification comparing WHO 5th vs ICC 2022 guidelines.
From screening tests to precision diagnosis of acquired and congenital coagulopathies.
Management in multiple myeloma and strategies for anti-Rh17 management.
Evolving practices and updates on mismatch unrelated hematopoietic stem cell transplantation.
Attendees may be eligible for CME credits. A Saudi Commission ID is required during registration to claim applicable credits.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
